BofA raises Tyson stock price target on strong chicken results

Tyson Foods beat fiscal Q2 2026 expectations with adjusted EPS of $0.87 versus $0.78 consensus and revenue of $13.65 billion versus $13.61 billion expected. BofA raised its price target to $70 from $68 and lifted FY2026 adjusted operating income guidance to $2.2 billion-$2.4 billion, driven by strength in Chicken, though Beef remains a drag. The stock is up 33% over six months and is trading near its 52-week high of $68.81.

Analysis

The key second-order read-through is that Tyson’s mix improvement is more valuable than the headline beat suggests: Chicken is acting as a margin reset lever across the protein complex, and that usually pulls shelf prices and contract negotiations higher with a lag. If Chicken stays constructive for another 1-2 quarters, the market will start underwriting a more durable earnings floor, not just a temporary recovery, which matters because TSN has been trading like a cyclical turnaround rather than a defensible cash-flow story.

The bigger competitive implication is for smaller and mid-cap protein producers with less scale in feed procurement and processing efficiency. If Tyson is using strength in Chicken to offset Beef volatility, competitors without that offset will look structurally weaker on spread capture and could be forced into more aggressive promo behavior, especially into summer grilling and back-to-school demand windows. That creates a potential winner/loser split inside packaged food and meat: high-quality operators with poultry exposure gain share, while pure beef-exposed names face a slower margin repair.

The main risk is that the market extrapolates too far on a single-quarter beat and ignores the fragility of protein spreads. A modest swing in feed costs or bird health can compress margins quickly over the next 1-2 quarters, and if Beef remains soft, the multiple expansion case stalls even if EPS revisions keep ticking up. At near highs, TSN is vulnerable to a classic “good news already in the price” setup if the next guidance update fails to show further upward revision velocity.

Consensus appears to be treating this as a clean operational inflection, but the more interesting view is that Tyson may simply be re-rating from depressed earnings power toward mid-cycle normalization. That leaves upside if Chicken proves persistent, but limited if the current quarter was mostly a spread timing benefit. In other words, this is less a momentum long and more a tactical long only while estimates are still being revised upward.

Key Decisions for Investors

• Stay long TSN only tactically for the next 1-2 quarters; use dips toward the post-earnings range as entry, but trim into strength near prior highs because the multiple is now more vulnerable to any guidance disappointment.
• Pair trade: long TSN / short a more beef-exposed protein name over the next 3-6 months to isolate the Chicken recovery versus the broader protein cycle; this is best if feed costs remain stable and poultry spreads stay firm.
• Buy TSN upside via call spreads rather than stock if you want exposure to continued estimate revisions; the risk/reward is better if the market keeps rewarding incremental guidance raises, but premium should be limited because the stock has already rerated.
• Set a hard risk trigger on any sign of margin compression in Chicken next quarter; if gross profit fails to expand again, the thesis shifts from structural recovery to one-quarter noise and the trade should be cut quickly.
• Watch for follow-through in analyst estimate revisions over the next 30-60 days; if revisions plateau while price stays elevated, that is a cue to fade the move rather than chase it.